Search Results 631-640 of 16388 for Interindividual

  1. Implementing Genomic Medicine in a Federally Qualified Health Center to Characterize Healthcare Provider and Patients Experiences - Mayo Clinic

    About this study. The purpose of this study is to characterize healthcare provider experiences caring for Latino/a patients receiving PRS in a Federally ...

  2. Immune thrombocytopenia (ITP) - Doctors and departments - Mayo Clinic

    Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, ...

  3. A Study to Evaluate Caregiver Connections via Technology for Patients with Alzheimer's and Other Types of Dementia - Mayo Clinic

    About this study. The purpose of this study is to optimize profile questionnaire and matching algorithm developed in Phase I and implement in final website ...

  4. Taselisib and Enzalutamide in Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast Cancer - Mayo Clinic

    Taselisib is a PI3K inhibitor. The PI3K pathway is involved is cancer growth. Androgen may cause the growth of tumor cells. Enzalutamide may stop the growth of ...

  5. An Extension Study to Evaluate Subjects Who Have Benefited from Previous Treatment with Niraparib - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  6. Safety and Tolerability of Atezolizumab (ATZ) in Combination With Radium-223 Dichloride (R-223-D) in Metastatic Castrate-Resistant Prostate Cancer (CRPC) Progressed Following Treatment With an Androgen Pathway Inhibitor - Mayo Clinic

    Safety and Tolerability of Atezolizumab (ATZ) in Combination With Radium-223 Dichloride (R-223-D) in Metastatic Castrate-Resistant Prostate Cancer (CRPC) ...

  7. Transcriptomic Changes Before And After Anti-tnf Therapy Utilizing Optimum Therapeutic Drug Levels - Mayo Clinic

    About this study. The purpose of this study is to evaluate infliximab drug levels and anti-infliximab antibody levels in HiSCR50/IHS4 responders versus ...

  8. Prospective, Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Symptomatic Celiac Disease Patients - Mayo Clinic

    About this study. This is a phase 2b, multicenter, prospective, randomized, double-blind, placebo-controlled, crossover study in symptomatic celiac disease ...

  9. A Study of the Natural History of Monoclonal Gammopathy of Undetermined Significance (MGUS) Over Time - Mayo Clinic

    About this study. The primary purpose of this study is to evaluate the risk of progression from Monoclonal Gammopathy of Undetermined Significance (MGUS) to ...

  10. Patient Stories - Matthew J. Binnicker - Mayo Clinic

    Fuel groundbreaking medical research! ... Your donation powers the future of medicine and helps save lives. Give Today.